Aaable Study Co News Today

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms

January 18, 2024

Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients&#039; lives, today announced initiation of a Phase II/III clinical trial (stAAAble) to investigate the safety and efficacy...

United States Jack Springer Hospital Of The University Pennsylvania Division Of Vascular Product Service Aaable Study Co

Source: lelezard.com

Navigation

Aaable Study Co News Today

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms

Explore More Categories

Navigation

Aaable Study Co News Today

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST&#xAE; System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST&#xAE; System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms

Explore More Categories

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms

Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms